Frontiers in Cardiovascular Biomedicine (FCVB) 2022 Budapest Is on in Person! the Excellent Programme Proves That Scientists Won Against COVID-19

Authors

Péter Ferdinandy, Cardiometabolic Research Group and MTA-SE System Pharmacology Research Group, Department of Pharmacology and Pharmacotherapy, Semmelweis University, Üllői út 26, Budapest 1085, Hungary.
Ákos Koller, Department of Morphology and Physiology, Faculty of Health Sciences, Budapest 1085, Hungary.Follow
Christian Weber, Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximillians-Universität (LMU) München, Munich, Germany.
Johann Wojta, Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria.
Johannes Waltenberger, Chair of Cardiology and Vascular Medicine, Medical Faculty, University of Münster, Münster, Germany.

Author Type(s)

Faculty

DOI

10.1093/cvr/cvac064

Journal Title

Cardiovascular Research

First Page

e59

Last Page

e61

Document Type

Article

Publication Date

6-29-2022

Department

Physiology

Recommended Citation

Ferdinandy, P., Koller, Á., Weber, C., Wojta, J., & Waltenberger, J. (2022). Frontiers in Cardiovascular Biomedicine (FCVB) 2022 Budapest Is on in Person! the Excellent Programme Proves That Scientists Won Against COVID-19. Cardiovascular Research, 118 (8), e59-e61. https://doi.org/10.1093/cvr/cvac064